NGM282 Significantly Reduces Hepatic Steatosis Independent of Type 2 Diabetes (T2D) Status or Statin Usage—Results from a Phase 2 Trial in Patients with Nonalcoholic Steatohepatitis (NASH)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • DEPAOLI, A; ROSSI, SJ; LING, LEI; HARRISON, SA; ABDELMALEK, MF; JAROS, MR; SOMARATNE, R

Published Date

  • May 2018

Published In

Volume / Issue

  • 67 / Supplement 1

Start / End Page

  • 1 - LB

Published By

Electronic International Standard Serial Number (EISSN)

  • 1939-327X

International Standard Serial Number (ISSN)

  • 0012-1797

Digital Object Identifier (DOI)

  • 10.2337/db18-1-lb